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Somatostatin triggers rhythmic 
electrical firing in hypothalamic 
GHRH neurons
Guillaume Osterstock1,2,3, Violeta Mitutsova1,2,3, Alexander Barre1,2,3, Manon Granier1,2,3, 
Pierre Fontanaud1,2,3, Marine Chazalon1,2,3, Danielle Carmignac4, Iain C. A. F. Robinson4, 
Malcolm J. Low5, Nikolaus Plesnila6, David J. Hodson7,8,9, Patrice Mollard1,2,3 &  
Pierre-François Méry1,2,3
Hypothalamic growth hormone-releasing hormone (GHRH) neurons orchestrate body growth/
maturation and have been implicated in feeding responses and ageing. However, the electrical 
patterns that dictate GHRH neuron functions have remained elusive. Since the inhibitory neuropeptide 
somatostatin (SST) is considered to be a primary oscillator of the GH axis, we examined its acute 
effects on GHRH neurons in brain slices from male and female GHRH-GFP mice. At the cellular 
level, SST irregularly suppressed GHRH neuron electrical activity, leading to slow oscillations at the 
population level. This resulted from an initial inhibitory action at the GHRH neuron level via K+ channel 
activation, followed by a delayed, sst1/sst2 receptor-dependent unbalancing of glutamatergic and 
GABAergic synaptic inputs. The oscillation patterns induced by SST were sexually dimorphic, and 
could be explained by differential actions of SST on both GABAergic and glutamatergic currents. Thus, 
a tripartite neuronal circuit involving a fast hyperpolarization and a dual regulation of synaptic inputs 
appeared sufficient in pacing the activity of the GHRH neuronal population. These “feed-forward loops” 
may represent basic building blocks involved in the regulation of GHRH release and its downstream 
sexual specific functions.
Hypothalamic growth hormone-releasing hormone (GHRH) neurons control the pulsatile secretion of growth 
hormone (GH) from the pituitary gland1, thereby regulating growth and metabolism. In addition, these neurons 
are involved in the central regulation of glucose homeostasis2. However, the hypothalamic circuitry that allows 
GHRH neurons to deliver the appropriate spiking pattern in response to stimulation remains poorly character-
ized. Indeed, the underlying mechanisms may involve quantitative and qualitative changes at both the cell and 
population levels.
The small contingent of GHRH neurons (< 2000) located in the arcuate nucleus project to the median emi-
nence, where GHRH secretion into the adjacent portal system triggers pituitary GH release. Symmetrically, 
neuroendocrine somatostatin (SST) neurons concentrated within the periventricular nucleus also project to the 
median eminence where they release SST to exert an inhibitory control over GH release. Successful models of the 
GH axis consistently incorporate two characteristic features: secretion is paced by the activity of GHRH neurons, 
and increasing somatostatin (SST) levels delay the inter-pulse intervals of GHRH secretion3–7. GHRH neurons 
are not inherently rhythmic at the electrical level, since patch-clamp studies in situ failed to reveal the presence of 
electrical oscillations in cell bodies8,9. Furthermore, central or peripheral stimulation of the GH axis8,9, as well as 
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hypoglycemic challenge2, has been shown to increase GHRH neuron spike-discharge, but with no real evidence 
of specific patterning. Thus, the simple scaling-up or –down the firing activity of GHRH neurons appears to be a 
robust mechanism involved in the control of pituitary GH secretion.
GHRH neurons also receive abundant synaptic inputs from both neuropeptide (i.e. SST)- and neurotransmit-
ter (i.e. GABA and glutamate)-releasing neurons8,10. Moreover, GHRH neurons express the relevant receptors, 
including SST1 and SST2 somatostatin receptor subtypes. Hence, GHRH neurons of may in fact be capable of 
displaying patterned/rhythmic electrical discharges, and this may stem from differential responsiveness to their 
afferent SST-, GABA- and glutamate inputs. The identification of the mechanisms underlying GHRH neuron 
activity are important, since defects in pulsatile GH release are associated with disorders of growth and impaired 
responses to hypoglycemia during diabetes1,11.
In the present study, we show that SST inhibited GHRH neuron electrical activity in brain slices from 
GHRH-GFP transgenic mice8,9. Notably, this inhibitory effect of SST was not sustained, leading to the emergence 
of oscillations in GHRH neuronal population activity. Mechanistically, these firing patterns depend on a basic 
circuit consisting of: i) a neuropeptide input (SST); ii) a parvocellular neuronal target (GHRH neuron); and iii) 
neuronal inputs releasing GABA and glutamate that allow GHRH neurons to escape SST-blockade. This hitherto 
unidentified tripartite system may thus form coherent and incoherent feed-forward loops12, which recur through-
out the arcuate nucleus to promote rhythms in GHRH release in response to physiological demands.
Materials and Methods
Study approval. Animal procedures complied with the welfare guidelines of the European Community 
and were ethically approved by the Direction of Veterinary departments of Herault, France (agreement number 
34.251) and the Languedoc Roussillon Institutional Animal Care and Use Committee, France (#CE-LR-0818).
Slice preparation for electrophysiological recordings. Adult 12–16 week-old GHRH-GFP mice8 or sst 
knockout mice13 were anesthetized by isoflurane inhalation, killed by decapitation, and brains quickly removed 
into cold (0–2 °C) solution-1 [in mM; 92 N-methyl-D-glucamine-Cl, 2.3 KCl, 1 CaCl2, 6 MgCl2, 26 NaHCO3, 
1.2 KH2PO4, 25 glucose, 0.2 ascorbic acid, 0.2 thiourea; pH 7.4 gassed with 95% CO2, 5% O2]8. Sagittal sec-
tions (300 μm-thick) were cut with a microtome (Integraslice 7550, Campden Inst., UK) and stored at 34 °C in 
solution-2 [in mM; 115 NaCl, 2.5 KCl, 1 CaCl2, 4 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, 25 glucose, 0.2 ascorbic 
acid, 0.2 thiourea; pH 7.4, gassed with 95% CO2, 5% O2] for at least 45 min.
Patch-clamp recordings. Slices were immobilized with a nylon grid in a submersion chamber on the stage 
of an upright microscope (Axioskop FS2, Carl Zeiss) and superfused with solution-3 [in mM; 125 NaCl, 2.5 
KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, 12 glucose; pH 7.4, gassed with 95% CO2, 5% O2] at a rate of 
1.6 ml/min for at least 15 min at 30–32 °C. We used similar temperatures to those employed during recordings 
of pituitary slices, so we could match up any alterations in GHRH firing with our previous studies on GH net-
work function14. Infrared differential interference contrast illumination was used to visualize neurons, with a 
x63 immersion objective and Nomarski differential interference contrast optics, and the images captured with an 
infrared camera (C2400, Hamamatsu Photonics, Massy, France). Borosilicate glass pipettes were connected to the 
head stage of an EPC-9/2 amplifier (HEKA, Ludwigshafen/Rhein, Germany) to acquire and store data using Pulse 
8.09 software (HEKA). As indicated, agonists were either bath-applied or ejected locally. When bath-applied, 
solutions were changed by switching the supply of the perfusion system. The latency of the superfusion change 
was verified on a daily basis. When ejected in the vicinity of the neurons with a glass pipet, compounds were 
diluted in a HEPES-based medium containing in mM: 138 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 3 NaHCO3, 1.25 
NaH2PO4, 10 HEPES, 12 glucose, pH 7.4 with NaOH. Slices were discarded after being exposed to an agonist. All 
chemicals were from Sigma-Aldrich (L’isle d’Abeau, France) except D-glucose (Euromedex, France).
For extracellular recordings of spontaneous action potentials, pipettes (5–7 MΩ ) were filled with (in mM), 130 
NaCl, 2.5 KCl, 10 HEPES, 10 Glucose, 2 CaCl2, 1 MgCl2, pH 7.4 with NaOH (295 mOsm adjusted with NaCl). 
Neuronal activity was recorded in the voltage clamp mode (0mV) of the loose-patch configuration8. Standard 
off-line detection of spontaneous action potentials was performed with Axograph 4.0 (Axon Instruments Inc., 
Foster City, CA). In brief, a template was generated and used to scan the raw trace for similar waveforms. All 
matching events were stored and, when present, false positive events were discarded, either manually or auto-
matically on the basis of their amplitude or kinetics. Other calculations and analysis were performed with 
IgorPro (Wavemetrics, Lake Oswego, OR). Mean action potential rate was calculated every 5 s, over the whole 
time course of the experiments, and normalized to the control level. For the quantification of GHRH neuronal 
population activity, the results of all similar experiments were aligned and averaged with respect to the time 
of the solution change. Intrinsic and inter-individual heterogeneity indices were calculated as |rate(tn) − rate 
(tn−1)|and |rate(tn) − mean rate(tn)|, respectively, for each data point. For the quantification of early and late effects 
of SST, the mean firing rates were calculated every 60 s, over the time course of the experiments. The amplitude 
of the early or late effects was selected as the maximal change occurring, respectively, during the first 10 min or 
10–20 min following agonist application.
For whole cell recordings8, pipettes (6–8 MΩ) were filled with solution containing in mM: 2.25 KCl, 125.3 
KMeSO3, 10 HEPES, 0.1 EGTA acid, 1 MgCl2, 2 MgATP, 0.5 Na-GTP, 5 Na2-phospocreatine, 2 Na-pyruvate, 
2 malate, pH 7.2 with KOH (295 mOsm adjusted with KMeSO3). In the current-clamp mode, the spontaneous 
fluctuations of the membrane potential were measured at 0 pA. The detection and calculation of the firing rate 
was identical as above, using the appropriate template, except that it was averaged every 2 s. For the calculation of 
the resting potential, time-series were filtered at 2 Hz, eliminating all peaks, and the amplitude averaged every 2 s.
In the voltage-clamp mode, steady-state or synaptic currents were recorded. Both spontaneous GABAergic, 
GABAzine-sensitive and glutamatergic, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX)-sensitive synaptic 
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currents were captured at − 30 mV and − 70 mV, respectively8. Miniature currents were recorded under the same 
conditions as synaptic currents, in the presence of 500 nM tetrodotoxin8. These events were extracted as described 
above for action potentials, using the appropriate template and filters, and their amplitudes, inter event intervals 
and densities (amplitude × instantaneous frequency) were plotted. For the calculation of mean values (amplitude, 
intervals, density), 60 s data bins were averaged from identical experiments with respect to the agonist applica-
tion. Early and late maximal effects of SST were calculated during the first 5 min and 10–20 min after agonist 
application. For steady-state recordings, neurons were voltage clamped at − 50mV and peak current and current 
at the end of SST application calculated. Decay rate was steady state current - peak current/steady state time - 
peak time. Similar experiments were performed in the presence of 6,7-dinitroquinoxaline-2,3-dione (DNQX) + 
GABAzine with identical results (data not shown).
Statistics. Normality was tested using the D’Agostino Omnibus test (Graphpad Prism). In the bar graphs, 
data were expressed as mean ± SEM and compared with a paired Student’s t test, using the appropriate sets of 
values. For the kinetics analysis of firing rates, data were expressed as mean ± SEM at each time point and com-
pared with a paired Student’s t test, to delineate the ranges of differences between control and agonist-treated 
distributions (p < 0.01 was taken as significant; ns, not significant). Mean distributions are represented as lines 
connecting the mean values, and error bars represent the SEM. For clarity, only a representative portion of the 
mean ± SEM values are shown in the graphs. Multifactorial comparisons of the data sets (between genders or 
drugs) were performed with a two-way repeated measure ANOVA (Graphpad Prism), or for non-parametric 
data, an ANOVA-type statistic (R Project)15. Comparisons between mean unpaired distributions were performed 
with a Mann-Whitney test (Graphpad), as indicated. In all cases, p < 0.05 was considered as significantly different.
Results
Acute somatostatinergic inhibition of GHRH neurons depends on GIRK activation. SST has 
been shown to induce profound electrical silencing through activation of G protein-gated inwardly rectifying 
potassium (GIRK)-currents16. Consistent with this, focal application of SST to GFP-tagged GHRH neuron somata 
triggered a transient hyperpolarizing response, which inhibited action potential firing in both male and female 
hypothalamic slice preparations (Fig. 1A,B). Furthermore, these SST responses could be prevented by bath 
application of barium ions (200 μM) to block GIRK channel conductance16,17. Quantification of SST-induced 
K+-currents (Fig. 1C) revealed no differences in either current amplitude or inactivation decay rates between 
males and females (Fig. 1D,E), suggesting that GHRH neurons respond to acute SST application in a sex-inde-
pendent manner.
Tonic somatostatin stimulation unveils delayed GHRH neuron firing patterns. To study 
longer-lasting effects of SST on neuronal activity18, GHRH electrical activity was monitored over dozens of min-
utes. Prolonged local ejection or bath application of SST both resulted in a transient hyperpolarization due to 
recurrent episodes of heightened GHRH neuron spiking activity (Fig. S1). These irregular patterns were unlikely 
to be associated with dilution of intracellular contents by the pipette solution, as identical results could be detected 
using loose patch-clamp to rule out cell dialysis artefacts19 (Fig. 2A). While the temporal profiles subtly differed 
from one neuron to another, the observed pattern in a given neuron was robust, since it could be reproduced by 
Figure 1. SST rapidly silences GHRH neuron activity. (A) Representative trace showing silencing of an 
identified GHRH neuron following local pressure ejection of somatostatin (SST). (B) Mean effects of SST 
treatment on spontaneous action potential firing (top) and resting potential amplitude (bottom) in GHRH 
neurons from male animals (n = 7). Data are averages of 2 sec bins. Statistically significant differences versus 
control (before SST application) are highlighted by the white area (P < 0.05, paired Student’s t test). (C) 5 min 
SST exposure induced an outward current in a GHRH neuron held at − 50 mV. (D) Mean SST-induced current 
densities in GHRH neurons at the onset (peak) and end (late) of 1 μM SST ejections. Males are shown in blue 
and females in red. (E) As for (D) but mean decay rates of the SST-induced current densities.
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repeat application of SST (Fig. 2B). On average, SST 10 nM did not induce a tonic inhibition in the majority of 
recorded neurons, in both males (Fig. 2C and Fig. S2A,C) and females (Fig. 2D and Fig. S2B,D). As a result, the 
GHRH population was able to escape from the inhibitory effects of SST. These alterations in mean firing activity 
were more rapid, frequent and varied in males compared to females (Fig. 2 and Fig. S3). Of note, analysis of the 
SEMs over time revealed sudden increases in the heterogeneity of the neuronal responses in males (Fig. 2C,D 
and Fig. S3A), and this was associated with significant differences in the intrinsic heterogeneity index (Fig S3B). 
Even at a higher SST concentration (100nM), electrical activity was still not homogenous in GHRH neurons of 
males, while it was severely attenuated to about 25% of its initial level in females (Fig. 2E,F and Fig. S3C). Indeed, 
at this concentration, the inter-individual heterogeneity index was higher in males versus female mice (Fig. S3D).
Sst1 and sst2 receptor activation mediates GHRH neuron firing patterns in response to soma-
tostatin. GHRH neurons express sst1 and sst2 receptors, and both subtypes are implicated in the control 
of GH secretion10,20–22. To investigate the relative contribution of these receptors to SST-induced oscillations in 
GHRH neuron electrical activity, selective agonists were employed23. Application of the sst2 agonist octreotide 
diminished the firing rates of GHRH neurons in slices derived from both male (Fig. 3A and Fig. S2E) and female 
GHRH-GFP mice (Fig. 3B and Fig. S2F). Although this inhibition was not necessarily homogenous at the single 
neuron level (Fig. 3A,B), the blunting effect of octreotide was tonic at the population level, with only few signifi-
cant escapes from sst2ergic inhibition in both male and female mice (Fig. 3C,D). Despite this, the heterogeneity 
of the responses was still slightly higher in males compared to females (Fig. S4A,B).
Next, we examined the effects of CH-275, an sst1 receptor agonist23–25. Application of CH-275 failed to signif-
icantly decrease spike frequency in both sexes (Fig. 3E,F and Fig. S2G,H), while SST was effective at modulating 
spike firing in the same experiments (Fig. 3E). However, when octreotide and CH-275 were co-applied, with the 
aim of mimicking the effects of SST, the mean behavior of the GHRH neurons was a prolonged and irregular 
inhibition in males (Fig. 3G and Fig. S2I), whereas shorter episodes of recurrent spiking were detected in females 
Figure 2. SST induces delayed oscillations in GHRH neuron spike firing. (A) Action potential firing 
frequency of a GHRH neuron from a male animal during SST superfusion (raw traces, above). (B) As for 
(A) but female animals. (C) Mean traces showing effects of 10 nM SST (applied t = 0 min) on spontaneous 
GHRH neuron action potential firing kinetics in male animals (n = 15). Frequencies are normalized (1 = max, 
0 = min). Grey (P > 0.01) and white (P < 0.01) shaded areas indicate significant differences in GHRH 
population electrical activity versus control (hatched line) (paired Student’s t test). The schematic above the 
traces shows the nature of the pooled population responses (ON, green; OFF, blue; heterogeneous, blue/green). 
(D) As for (C) but female animals (n = 19). (E) As for (C) but responses to 100 nM SST (n = 14). (F) As for  
(E) but female animals (n = 13). The control action potential frequencies were 1.92 ± 0.5 Hz in (C); 
1.61 ± 0.5 Hz in (D); 2.61 ± 0.6 Hz in (E); and 2.24 ± 0.4 Hz in (F).
www.nature.com/scientificreports/
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(Fig. 3H and Fig. S2J). Accordingly, firing rate heterogeneity (SEM) was enhanced by CH-275 in both males and 
females (Fig. S4C,D), but this effect was significant over a prolonged period of time in males only (i.e., from 8 to 
20 minutes, Fig. S4C). These findings suggest that the pattern induced by SST occurs as a result of a dual activa-
tion of sst1 and sst2 receptors. Excluding a confounding role for endogenous SST release, experiments with SST, 
CH-275 and octreotide were repeated in sst knockout mice3,13, with similar results (Fig. S5). These results suggest 
that sst2 activation might account for the tonic inhibition induced by SST, while simultaneous sst1 recruitment 
would promote the irregular, rebound-like, pattern.
Glutamatergic and GABAergic inputs set the tempo in GHRH neurons upon sustained somato-
statin stimulation. The spontaneous firing activity of GHRH neurons is mainly driven by a local (hypotha-
lamic) balance between glutamatergic (excitatory) and GABAergic (inhibitory) neuronal inputs8,9. We therefore 
sought to determine whether SST-induced GHRH firing patterns could be associated with indirect synaptic 
effects. In both sexes, SST inhibited both glutamatergic (Fig. 4A–C and Fig. S6A,B) and GABAergic (Fig. 4E–G 
Figure 3. SST acts through sst1 and sst2 to inhibit GHRH neuron activity. (A) 100 nM Octreotide 
superfusion suppresses action potential firing frequency in male GHRH-GFP neurons. (B) As for (A) but 
female animals. (C) Mean traces showing GHRH neuron action potential firing kinetics in male animals 
following application of the sst2 agonist octreotide (n = 16). Frequencies are normalized (1 = max, 0 = min). 
Grey (P > 0.01) and white (P < 0.01) shaded areas indicate significant differences in GHRH population 
electrical activity versus control (hatched line) (paired Student’s t test). (D) As for (C) but female mice (n = 12). 
(E) Bath application of the sst1 agonist CH-275 does not alter GHRH neuron action potential firing rate in 
male animals. SST was used as a positive control. (F) As for (E) but female animals. (G) Mean traces showing 
delayed recovery from octreotide suppression in CH-275 treated male GHRH neurons (n = 13). (H) As for (G) but 
showing appearance of recurrent spiking activity in females (n = 15). In all cases, compounds were introduced at 
t = 0 min. The control action potential frequencies were 3.22 ± 0.8 Hz in (C); 1.38 ± 0.2 Hz in (D); 1.53 ± 0.4 Hz in 
(G); and 1.97 ± 0.4 Hz in (H).
www.nature.com/scientificreports/
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and Fig. S4C,D) synaptic currents after a lag period of a few minutes. Notably, SST robustly decreased the magni-
tude of glutamatergic inputs in all females, but only two thirds of males (Fig. 4D). Suggesting that these properties 
were sexually dimorphic, the opposite convention was observed for GABAergic currents (Fig. 4H). By contrast, 
when present, the inhibitory effects of SST on glutamatergic currents in GHRH neurons possessed similar prop-
erties in females (7 out of 7 neurons) and in males (10 out of 17 neurons). The inhibitory effects of SST on 
GABAergic transmission were also similar in the responsive neurons in females (5/8) and males (10/10). From 
this, the strength of SST-induced inhibition on GHRH neuronal population electrical activity would be expected 
to be underlined by the proportion of neurons sensitive to synaptic modulations.
Therefore, we further explored whether sst receptor activation was able to generate rhythmic electrical activity 
in GHRH neurons through delayed modulation of glutamatergic and GABAergic currents. While glutamatergic 
input almost entirely accounted for GHRH neuron excitation (Fig. 4D), an analysis of these currents failed to 
detect a sustained coordination at the multi-neuronal level (Fig. S7A,B). By contrast, GABAergic currents were 
coordinated during a long-lasting application of SST (Fig. S7C), suggesting that they may play a critical role 
in driving oscillatory GHRH neuron firing patterns. Moreover, the sst1 agonist CH-275 increased GABAergic 
miniature current (mIPSC) interval but not amplitude (Fig. 4I,J), supporting a role for presynaptic modulation of 
Figure 4. Inhibition of GHRH neuron synaptic currents by SST. (A) Raw traces showing spontaneous 
glutamatergic currents in female GHRH neurons held at − 50mV (a, b and c represent before, during and 
after SST, respectively, and correspond to the regions shown in (C)). (B) Glutamatergic current frequency in 
male GHRH neurons following 100 nM SST superfusion. (C) As for (B) but showing a reduction in current 
density in SST-treated female slices. (D) Bar graph showing proportion of GHRH neurons displaying reduced 
glutamatergic currents in response to SST (n = 17 for males and n = 7 for females). Mean latencies for the effects 
were 3.4 ± 0.4 min and 4.6 ± 0.5 min in males and females, respectively. (E) Raw traces showing spontaneous 
GABAergic currents in male GHRH neurons (a, b and c represent before, during and after SST, respectively, and 
correspond to the region shown in (F)). (F) SST reduces GABAergic current density in male GHRH neurons. 
(G) As for (F) but showing a less potent action of SST to reduce currents in females. (H) Bar graph showing 
proportion of GHRH neurons displaying reduced GABAergic currents in response to SST (n = 10 for males 
and n = 8 for females). Mean latencies for the effects were 3.8 ± 0.6 min and 3.8 ± 0.7 min in males and females, 
respectively. (I,J) The sst1 agonist CH-275 increased miniature GABAergic current (mIPSC) intervals, but 
not their amplitude, in male GHRH neurons (recorded in the continued presence of 500nM tetrodotoxin). 
*P < 0.05 and ***P < 0.005 versus control (t = 0 min) (paired Student’s t- test). Under control conditions, 
intervals (I) and amplitudes (J) were respectively 0.4 ± 0.1 s and 16 ± 3 pA.
www.nature.com/scientificreports/
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GHRH neuron GABAergic synapses. Together, these findings suggest that the time course of presynaptic modu-
lation (i.e. inhibition of inhibitory inputs) was similar to that of the spike patterns detected during SST application 
(Fig. 2A).
Discussion
We show here the existence of long-lasting rhythms of electrical activity in GHRH neurons exposed to SST. These 
irregular episodes of spike firing involved activation of both sst1 and sst2 receptors, and could only be evidenced 
at the population level. Strikingly, these patterns in GHRH neuron activity displayed a sexual dimorphism, and 
this was primarily attributable to a sex-dependent control of GABAergic and glutamatergic inputs by SST, rather 
than intrinsic differences in the GHRH neurons themselves. We thus hypothesize that simple tripartite hypotha-
lamic circuits underlie growth and metabolism by pacing GHRH output.
GHRH neurons are unlikely to express the inherent capability to generate recurrent episodes of electrical 
activity in situ8,9. This is not unexpected, however, since a variety of neurotransmitters and hormones are able to 
modulate the electrical activity of GHRH neurons in the arcuate nucleus, and/or to modulate GHRH secretion 
at the median eminence20. So far, none of these factors, including carbachol, ghrelin, NPY, SST, and glucose 
have been found to orchestrate oscillations in GHRH neuronal activity2,4,7–9,20. The build-up of such firing pat-
terns occurs at the population level when sustained SST stimulation activates a hypothalamic circuit comprised 
of GHRH neurons, together with their GABAergic and glutamatergic inputs. Various studies, including the 
present one, show that SST requires the activation of both sst2 and sst1 receptors10,20–22,26, and GHRH neurons 
express both receptor types5,21,24,25. Sst1 receptors appear tightly involved in the SST-ergic control (inhibitory) of 
GABAergic inputs24,25, which is likely to take place at the presynaptic level, being effective at modulating the inter-
vals and not the amplitude of miniature GABAergic currents. Given that glutamatergic inputs are able to depolar-
ize cell bodies beyond the threshold for action potential firing via summation of small-amplitude EPSPs27, such 
a circuit appears to be robust enough to support patterned electrical activities. In the present study, we provide 
pharmacological evidence for the involvement of sst1 and sst2 receptors in GHRH neuron rhythmicity, in agree-
ment with prior anatomical, biochemical and physiological studies showing their role in the central regulation of 
GH secretion. While octreotide binds equally to sst2 and sst5 receptors, we think the latter subtype is unlikely to 
contribute to the present observations, since expression is largely limited to the cerebellum and pituitary28.
Revisiting how hypothalamic GHRH neurons deliver a spike firing code. Figure 5A schematizes 
how SST inhibition might allow glutamatergic and GABAergic inputs to form a tripartite hypothalamic circuit 
with GHRH neurons. This likely involves the following events:
Figure 5. Schematic of the feedforward loops proposed to underlie GHRH rhythm generation by SST.  
(A) The feedforward loop (FFL) allows precise temporal control over GHRH neuron electrical activity 
via dynamic effects on inhibitory and stimulatory drive. Strengths of GIRK activation, glutamatergic and 
GABAergic inputs are colored in red, green and violet, respectively. Grey shaded areas illustrate episodes of 
GHRH neuron firing. (B) At the circuit level, the FFL motifs consist of a primary regulator, SST, which inhibits 
secondary regulators (glutamatergic or GABAergic inputs) that synapse with GHRH neurons. The network 
motif involving glutamatergic inputs provides a delayed excitatory source (coherent FFL; see12 for definitions), 
whereas the motif with GABAergic inputs acts as a pulser (incoherent FFL). Both sst1 and sst2 receptors are 
involved in SST responses, with sst1 receptors notably acting to intermittently delay GABA current onset (pulse 
generator). The sexually dimorphic spiking rhythms recorded in GHRH neurons were associated with a sex-
dependent SST-regulation of linked FFLs but not GIRK currents in GHRH neurons (signs colored in red). Signs 
for inhibitory and stimulatory interneuron effects are colored in violet and green, respectively. Sign thickness 
represents the response magnitude. The “AND” gate sign represents the link between both coherent and 
incoherent FFLs, which recurs within the arcuate nucleus.
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•	 Step 1: Early and transient hyperpolarization of GHRH neurons. Altogether, our results suggest that sst2 recep-
tors recruit GIRK channels with a short latency, switching off GHRH neuron action potential firing. GIRK 
channels, which inactivate/desensitize within a few mins, likely participate in an early transient inhibition of 
GHRH neurons.
•	 Step 2: Delayed and sustained inhibition of GHRH neuron activation. Tonic SST receptor activation leads to a 
delayed and long-lasting decrease in glutamatergic transmission.
•	 Step 3: Delayed and temporary dis-inhibition of GHRH neurons. Sst receptor activation exerts a delayed sup-
pression of the inhibitory GABA currents, as reported in other brain regions29. The rapid GIRK current inac-
tivation/desensitization, together with this coordinated and temporary drop in inhibitory inputs, may be 
sufficient to enable spike escapes in GHRH neuron firing (Fig. 5A).
Although further studies will be needed to elucidate the precise mechanisms underlying delayed SST effects, 
the sequential modulation of hypothalamic interneurons may represent an initial step in the generation of pat-
terned GHRH spike firing6,30. This modulation likely participates in the sexual dimorphism of the GH axis, as 
there were qualitative and quantitative differences in the SST inhibition of GHRH neurons in males and females. 
Briefly, it was more regular and more tonic in GHRH neurons of females than males, especially at the highest 
SST concentration of 100nM. At the cellular level, glutamatergic neurotransmission was an obligatory target 
of SST in females, providing a mechanism for a more tonic inhibition, unlike in males where it was absent in 
one-third of GHRH neurons. Strikingly, the SST-ergic modulation of GABA inputs was a mirror image of that in 
glutamatergic neurons, being especially robust and synchronized in males. Whether the proportion of synapses 
engaged in the modulatory effects of SST varies with time warrants further studies. This would be a flexible 
mechanism for adapting the central control of the GH axis during the oestrous cycle, for instance, or in response 
to feeding status31,32. While female mice were randomly cycling, we think it unlikely that SST-ergic-regulation of 
GHRH neuron firing closely follows the oestrous cycle, since the SST-ergic effect could be qualitatively different 
in GHRH neurons from a given mouse. Moreover, responses in male animals were more varied than those in 
female animals, suggesting that hormonal status may homogenize GHRH population activity. Nonetheless, fur-
ther experiments, for example in ovariectomized animals supplemented with or without E2, would be required 
to investigate this.
SST engages both coherent and incoherent feed-forward loops to drive rhythmic firing in 
GHRH neurons. The regulatory circuits reported here share features consistent with the ‘parallel inhibi-
tion’ building block model of synaptic connectivity33, as well as feedforward loop motifs (so-called FFL). These 
phylogenetically-conserved mechanisms are reported to play central roles in metabolic, transcriptional and neu-
ronal networks12,34–40. Hypothalamic circuits involving stimulatory (glutamatergic) inputs may act as a coherent 
FFL, providing delayed responses to a persistent stimulus. Those characterized by inhibitory (GABAergic) inputs 
may function as an incoherent FFL, acting to pulse activity, as illustrated by the transient inhibitory effects of the 
sst1 agonist at the synaptic GABAergic level (see Fig. 4I). Both coherent and incoherent feedforward neuronal 
circuits may be widespread amongst GHRH neurons (Fig. 5B), although they are not a prerequisite. Indeed, in 
response to SST, a proportion of GHRH neurons did not exhibit glutamatergic or GABAergic modulations in 
males and females, respectively. Nevertheless, SST is essential for the sexual dimorphism of GH secretion, sug-
gesting that a similar circuitry may operate in vivo to mediate growth and metabolism3.
Conclusion
The present study unveils local hypothalamic connections that form FFLs to determine rhythmic firing pat-
terns in GHRH neurons. Such discrete hypothalamic circuits may be important sites of sex-imprinting of GH 
axis output, leading to divergent metabolic traits in males and females20,41–44, as well as representing a target for 
the central mechanisms underlying GHRH-dependent regulation of glucose homeostasis and food intake2,45,46. 
Consequently, our results shift the focus from the GHRH neurons themselves, towards the glutamate and GABA 
neurons that drive GHRH secretion.
Further studies are now warranted to explore whether interplay between FFLs may be important for coding 
information in other sets of hypothalamic neurons that receive glutamatergic and GABAergic inputs47–50 and 
display neuromodulation in response to neuropeptides51; for example, anorexigenic POMC and orexigenic AgRP 
neurons52. In addition to other regulatory mechanisms, such as tonic activity changes2, increased number of 
active neurons53, and modulation at the nerve terminal level54, FFL motifs may thus provide a mechanism55,56 to 
maintain hypothalamic circuit robustness in the face of perturbed metabolic homeostasis57,58.
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